M
10b5-1 Plan
$ Value
$0
Shares
10,491
Price
$0
Filed
Jan 13
Insider
Name
Mulay James
Title
—
CIK
0001684531
Roles
Director
Transaction Details
Transaction Date
2026-01-09
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
5,240
Footnotes
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. | The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023. | The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024.
Filing Info
Mulay James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | CGON | M | $571K |
| 2026-04-17 | CGON | ▼ | $1.1M |
| 2026-04-17 | CGON | M | $0 |
| 2026-01-09 | CGON | M | $2K |
| 2026-01-09 | CGON | ▼ | $29K |
| 2026-01-09 | CGON | M | $132K |
| 2026-01-09 | CGON | ▼ | $556K |
| 2026-01-09 | CGON | M | $0 |
| 2026-01-09 | CGON | M | $0 |
| 2025-10-09 | CGON | M | $22K |
Other Insiders at CGON (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
DETORE JAMES M.
Chief Financial Officer
|
— | — | 2026-04-15 |
| Mulay James | — | $1.1M | 2026-04-17 |
|
Patterson Joshua F.
See Remarks
|
— | — | 2026-04-15 |
|
Bellete Ambaw
President and COO
|
— | — | 2026-04-15 |
|
Kuan Arthur
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Kasturi Vijay
Chief Medical Officer
|
— | — | 2026-04-15 |